Jan 10, 2022 / 02:45PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst
All right. We'll get started. Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Priyanka Grover, Malcolm Kuno and Caleb Smith from the team.
Our next presenting company is Alnylam and presenting on behalf of the company, we have CEO, Yvonne Greenstreet. I want to remind all the attendees that there's an ask a question feature in the portal. And if you put a question in there, I'm happy to ask on your behalf during the session.
With that, Yvonne, if you want to take the way.
Yvonne L. Greenstreet - Alnylam Pharmaceuticals, Inc. - CEO & Director
Thanks, Anupam. Look, it really is an honor to be speaking to all of you today in my first public presentation as Alnylam CEO, and I couldn't be more excited about Alnylam prospects.
Let's move to Slide 2. During my remarks this morning, I will be making some forward-looking statements.
Next
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers